« Medtronic Inc. Suspends Sale of Sprint Fidelis Defibrillation Leads | Main | More Great Blog Action Day Posts »

Oct15
AstraZeneca's Nexium

Most people have heard of "the purple pill" but do you know what it's for?

AstraZeneca's (NYSE:AZN) Nexium (esomeprazole magnesium) is for the relief of persistent heartburn. Heartburn is considered "persistent" if you experience it two or more days a week.

What makes Nexium different from standard antacid (yes, we all use to take TUMS for heartburn before) is that it actually heals erosions in the esophagus. Acid churning up for the stomach can, over time, wear away the lining of the esophagus causing erosions that are not healed by antacids.

NexiumTreatment is usually 1 pill a day, at least 1 hour before a meal with a full glass of water. Though the symptoms of GERD/NERD may cease, continue the treatment for the entire length of time prescribed by your doctor.

Less serious side effects include: diarrhea, dry mouth, headache, nausea, stomach pain or constipation.

Nexium was the second best selling prescription drug according to Drug Topics 200 Top Brand Name Drugs By Retail Dollar in 2006 with retail sales of over $4,000,000,000 up 18% from 2005.


2 Comments/Trackbacks




» Stock Market Fluctuations in Big Pharmas as of February 8, 2008 from PharmaGazette
Company Name, Symbol, Share Price, ChangeAbbott Laboratories' (NYSE:ABT) - $56.80 -1.30 (-2.24%) AstraZeneca (NYSE:AZN) - $37.96 -0.76 (-1.96%) Bristol-Myers Squibb (NYSE:BMY) - $23.07 -0.27 (-1.16%) Eli Lilly & Co. (NYSE:LL... [Read More]

» Drug Sales in U.S. Have Slowest Growth Rate since 1961 from PharmaGazette
IMS Health released compiled data that showed that prescription drug sales rose by 3.8 percent in 2007 making it the slowest growth rate in over 45 years.Total sales were $286.5 billion in 2007 with a growth rate of 3.8%. Prescription... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Medtronic Inc. Suspends Sale of Sprint Fidelis Defibrillation Leads | Main | More Great Blog Action Day Posts »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb